Retinal Diseases

Globally, millions of people living with retinal conditions face a progressive decline in their independence and connection to the world due to vision loss.¹ Today, treatment often starts when degeneration in eyes has already occurred, resulting in avoidable vision loss for many. At Boehringer Ingelheim, we are working towards a better tomorrow. We are exploring innovative research pathways to help us understand degenerative retinal disease progression and deliver a unique and diverse pipeline of multiple drug candidates and progressive technologies to enable earlier detection and intervention. Our ambition is clear: to transform the retinal health landscape, developing targeted solutions that allow us to preserve the retina, protect people’s way of life and prevent vision loss.